U.S. Chemicals Stock News

NYSE:AROC
NYSE:AROCEnergy Services

Is Archrock's (AROC) 2026 Backlog Strength Quietly Rewriting Its LNG Demand Story?

Archrock Inc., a major U.S. natural gas compression services provider, recently entered its latest earnings season with strong investor attention and a forthcoming earnings report that was scheduled for May 5, 2026. Investors appear focused on Archrock’s heavily contracted 2026 backlog and its positioning to benefit from LNG-linked demand, even as some analysts have turned more cautious on near-term earnings. With Archrock’s heavily contracted 2026 backlog in focus, we’ll examine how this...
NYSE:ABG
NYSE:ABGSpecialty Retail

Is It Time To Reconsider Asbury Automotive Group (ABG) After Recent Share Price Weakness?

If you are wondering whether Asbury Automotive Group at around US$201 a share looks appealing or expensive, the starting point is understanding what the current price actually reflects. The stock has seen mixed recent returns, with a 0.5% decline over 7 days, a 4.1% gain over 30 days, a 14.2% decline year to date and a 7.7% decline over the past year. These moves can change how investors think about both upside potential and risk. Recent coverage around Asbury has focused on its position in...
NYSE:FCN
NYSE:FCNProfessional Services

Is FTI Consulting (FCN) Pricing Look Fair After Recent Share Price Moves

If you are trying to work out whether FTI Consulting is attractively priced or not, the recent share performance and current valuation signals give you some clear starting points to assess. The stock last closed at US$179.33, with returns of 3.1% over 30 days, 5.3% year to date and 7.8% over the past year. The 7 day return of a 3.2% decline and the modest 3 year return of 1.3% sit in the background for anyone thinking about timing. This article was prompted to provide ongoing coverage of FTI...
NYSE:TDG
NYSE:TDGAerospace & Defense

Assessing TransDigm Group (TDG) Valuation After Recent Share Price Volatility

Why TransDigm Group (TDG) is Back on Investor Radar TransDigm Group (TDG) has drawn fresh attention after recent share price volatility, with the stock showing a small gain over the past month but a weaker performance over the past 3 months and year. See our latest analysis for TransDigm Group. At a share price of US$1,142.74, the stock has seen a 7 day share price return of 3.79% decline and a 90 day share price return of 19.64% decline, while the 5 year total shareholder return of...
NasdaqGS:EXEL
NasdaqGS:EXELBiotechs

Is It Too Late To Consider Exelixis (EXEL) After Strong Five Year Share Price Gains?

If you are wondering whether Exelixis at around US$44.69 still offers value or has already priced in much of its story, the starting point is to look closely at what you are paying relative to what you are getting. The stock has had a mixed short term run, with an estimated 3.0% decline over the last 7 days, a 4.2% gain over the past month, a 2.5% return year to date, and a 14.9% return over the last year, sitting alongside a very large 3 year return and a 92.5% return over 5 years. Recent...
NYSE:EQT
NYSE:EQTOil and Gas

Is It Too Late To Consider EQT (EQT) After Its Multi Year Share Price Surge?

Wondering if EQT at around US$59.11 is offering good value right now, or if the easy gains are behind it? This article walks through that question step by step. The stock has returned 0.7% over the last 7 days, 10.6% year to date, and 21.0% over the past year, even with an 8.3% decline across the last 30 days, as well as a 96.2% return over 3 years and 212.7% over 5 years. Recent coverage around EQT has focused on its position within the US energy sector and how investors are reassessing...
NasdaqGS:KLIC
NasdaqGS:KLICSemiconductor

A Look At Kulicke And Soffa (KLIC) Valuation After Sectorwide AI And Geopolitical Concerns

A broad semiconductor selloff, tied to worries about slower artificial intelligence spending and rising geopolitical risks, recently pulled Kulicke and Soffa Industries (KLIC) lower as investors reacted to headlines about an AI leader missing internal targets. See our latest analysis for Kulicke and Soffa Industries. Even with the recent sector driven drop, Kulicke and Soffa’s recent 30 day share price return of 27.36% and 1 year total shareholder return of 164.64% suggest momentum has been...
NasdaqGS:KNSA
NasdaqGS:KNSABiotechs

Is It Too Late To Consider Kiniksa Pharmaceuticals (KNSA) After Its 91% One-Year Surge?

If you are wondering whether Kiniksa Pharmaceuticals International at around US$52.99 is genuinely good value or just riding sentiment, the starting point is to look closely at what the current price implies. The stock shows recent returns of 23.1% over 7 days, 10.1% over 30 days, 26.2% year to date and 91.0% over the past year, which naturally raises questions about how much of the story is already reflected in the share price. Recent news around the company has focused on its position...
NasdaqGM:MRLN
NasdaqGM:MRLNAerospace & Defense

Sizing Up Merlin (MRLN) After Volatile Returns And An Unusual Price To Book Valuation

Merlin (MRLN), a Boston based developer of AI powered autonomous flight software, has drawn attention after recent share price volatility. The return of 17.28% over the past month contrasts with weaker longer term performance. See our latest analysis for Merlin. The recent 17.28% one-month share price return comes after a sharp 25.43% one-day decline and a 19.74% year-to-date share price loss, suggesting momentum has been choppy rather than consistently building. If Merlin has put autonomous...
NasdaqGS:GLPI
NasdaqGS:GLPISpecialized REITs

Assessing Gaming and Leisure Properties (GLPI) Valuation After Strong Q1 Results and Updated Growth Outlook

Why Gaming and Leisure Properties Is Back in Focus After Q1 Earnings Gaming and Leisure Properties (GLPI) is drawing fresh attention after reporting first quarter 2026 results that showed higher sales and net income year over year, alongside updated guidance and detailed capital deployment plans. See our latest analysis for Gaming and Leisure Properties. The share price has picked up recently, with a 9.19% 1 month share price return and an 8.04% year to date share price return. The 5 year...
NYSE:BKSY
NYSE:BKSYProfessional Services

A Look At BlackSky Technology's Valuation As A US$25 Million Defense Contract Confirms Gen 3 And AI Demand

BlackSky Technology (BKSY) is in focus after securing a competitive multi year Assured subscription contract worth US$25 million with a major international defense customer, centered on its Gen 3 imagery and AI analytics. See our latest analysis for BlackSky Technology. The new Assured contract lands after a volatile stretch for BlackSky, with a 30 day share price return of 44.5% and year to date share price return of 52.1%, while the 1 year total shareholder return is very large, pointing to...
NYSE:FAF
NYSE:FAFInsurance

First American Bets On AI Title Tool As Valuation Questions Linger

First American Title Insurance Company, part of First American Financial (NYSE:FAF), has introduced AgentNet® Assist: Title Intelligence, an AI assisted document analysis tool for title professionals. The tool is designed to streamline title search workflows and is rolling out in phases to internal teams and title agents. For investors tracking First American Financial at a share price of $71.12, this launch points to a focus on product development rather than just incremental process...
OTCPK:FMCC
OTCPK:FMCCDiversified Financial

A Look At Freddie Mac’s (OTCPK:FMCC) Valuation As It Rolls Out VantageScore 4.0 Credit Assessments

Why Freddie Mac’s credit score shift matters for Federal Home Loan Mortgage (FMCC) investors Federal Home Loan Mortgage (FMCC) is beginning to accept mortgage loans assessed using VantageScore 4.0 with a limited lender rollout, a change aligned with federal efforts to modernize credit scoring and broaden access. See our latest analysis for Federal Home Loan Mortgage. At a share price of US$6.57, Federal Home Loan Mortgage has shown short term share price pressure with a 1-day share price...
NasdaqGS:BMRN
NasdaqGS:BMRNBiotechs

BioMarin Amicus Deal Expands Rare Disease Reach And Adds Kidney Asset

BioMarin Pharmaceutical (NasdaqGS:BMRN) has completed its acquisition of Amicus Therapeutics. The deal adds two approved lysosomal storage disease treatments to BioMarin's rare disease portfolio. BioMarin also gains an investigational kidney disease therapy that is in late stage development. For you as an investor, this deal expands what BioMarin already does in rare genetic conditions by adding more marketed products in lysosomal storage diseases and an asset in kidney disease. Rare...
NYSE:XPEV
NYSE:XPEVAuto

Is XPeng’s (XPEV) Physical AI Bet Reframing Its Global Competitive Edge?

In April 2026, XPeng unveiled its expanded Physical AI ecosystem at Auto China, showcasing its VLA 2.0 intelligent driving system, new GX robotaxi-oriented model, Mona M03, next P7 and X9, alongside the IRON humanoid robot and Land Aircraft Carrier flying car, while also outlining plans for global commercialization and overseas production of its driver-assistance technology. At the same time, XPeng moved to scale its international reach by entering Mexico with a three-year Latin America...
NasdaqGS:GLBE
NasdaqGS:GLBEMultiline Retail

Is It Time To Reassess Global E Online (GLBE) After Its Recent Share Price Pullback

If you are trying to figure out whether Global-E Online is attractively priced at around US$31.41, it helps to step back and look at the full valuation picture rather than focusing only on the latest quote. The stock has seen mixed returns, with a 9.7% move over the past 30 days, set against a 17.0% decline year to date and a 12.5% decline over the last year. The 3 year return sits at 16.3%. Recent news coverage has focused on Global-E Online as a specialist in enabling cross border...
NasdaqGS:VRSK
NasdaqGS:VRSKProfessional Services

Verisk Analytics (VRSK) Margin Compression Tests Bullish Narratives Ahead Of Q1 2026 Earnings

Verisk Analytics (VRSK) has just opened its Q1 2026 reporting season with a backdrop of steady recent fundamentals, including Q4 2025 revenue of US$778.8 million and basic EPS of US$1.42, supported by trailing twelve month revenue of about US$3.1 billion and EPS of US$6.50. Over recent quarters the company has seen revenue move from US$716.8 million in Q2 2024 to US$753 million in Q1 2025 and then to US$778.8 million in Q4 2025. Quarterly EPS has ranged between US$1.42 and US$2.16, setting up...
NasdaqGS:HTZ
NasdaqGS:HTZTransportation

How Does Pershing Square’s New Stake Reframe Hertz’s (HTZ) Long-Term Mobility Investment Narrative?

Earlier this week, Pershing Square’s London-listed vehicle confirmed it had taken a new position in Hertz Global Holdings, as part of a broader investment effort linked to its planned US$5.00 billion New York IPO that is largely backed by institutional investors. This move places Hertz within the orbit of a high-profile fund manager, potentially increasing scrutiny of its business model and long-term mobility exposure. Next, we’ll examine how Pershing Square’s newly disclosed Hertz stake...
NasdaqGS:JAZZ
NasdaqGS:JAZZPharmaceuticals

Will Ziihera’s Priority Review in First-Line HER2-Positive Gastric Cancer Shift Jazz Pharmaceuticals’ (JAZZ) Narrative?

Jazz Pharmaceuticals recently announced that the FDA previously accepted, with Priority Review, its supplemental Biologics License Application for Ziihera (zanidatamab-hrii) combinations in first-line treatment of adult patients with HER2-positive unresectable locally advanced or metastatic gastric, gastroesophageal junction, or gastroesophageal adenocarcinoma, with an August 25, 2026 PDUFA target action date. This filing, backed by Phase 3 HERIZON-GEA-01 data and supported by Breakthrough...
NYSE:FR
NYSE:FRIndustrial REITs

A Look At First Industrial Realty Trust (FR) Valuation After Earnings Jump And Activist Investor Campaign

First Industrial Realty Trust (FR) just paired a first quarter earnings update with fresh 2026 guidance, while facing active pressure from Land & Buildings Investment Management over board composition and capital allocation priorities. See our latest analysis for First Industrial Realty Trust. The share price has cooled in the last week, with a 1-day share price return of a 1.76% decline and a 7-day share price return of a 3.11% decline, after a recent 30-day share price return of 7.20%. The...
NasdaqGS:KHC
NasdaqGS:KHCFood

Is Capri Sun Hydrate a Turning Point in Kraft Heinz's (KHC) Health-Focused Brand Strategy?

Earlier this month, Kraft Heinz’s Capri Sun brand launched Capri Sun Hydrate, an electrolyte drink for kids with half the sugar of leading sports drinks and no artificial ingredients, now rolling out nationwide in major retailers. This kid-focused hydration drink highlights Kraft Heinz’s innovation push in better-for-you beverages, aligning product development with evolving family health preferences. We’ll now examine how Capri Sun Hydrate’s health-oriented innovation could influence Kraft...
NasdaqGS:WTW
NasdaqGS:WTWInsurance

A Look At Willis Towers Watson (WTW) Valuation After Recent Share Price Weakness

Why Willis Towers Watson (WTW) Is on Investors’ Radar Today Willis Towers Watson (WTW) is drawing fresh attention as investors reassess its recent share performance, with negative returns over the past month and past 3 months standing against solid multi year total returns. See our latest analysis for Willis Towers Watson. Recent trading has been soft, with a 90 day share price return showing an 8.62% decline and a year to date share price return showing an 11.08% decline, while the 3 year...
NYSE:JBL
NYSE:JBLElectronic

The Bull Case For Jabil (JBL) Could Change Following New Dividend And AI Optical Partnership News

Jabil Inc. recently declared a quarterly dividend of US$0.08 per share, payable on June 2, 2026, to shareholders of record on May 15, 2026, extending a track record of consecutive quarterly cash dividends on common shares that began in 2006. Ahead of its upcoming earnings report, Jabil’s new partnership with Sivers Semiconductors on low-energy AI data center optical modules highlights how the company is tying its long-running capital returns program to innovation in power-efficient...
NYSE:NYT
NYSE:NYTMedia

Is It Too Late To Consider New York Times (NYT) After Its Strong 1-Year Rally?

Wondering if New York Times at around US$79 is still offering value after a strong run, or if you are arriving late to the story? This article breaks down what the current price really implies. The stock closed at US$79.03, with a 1.8% drop over 7 days and a 5.1% decline over 30 days, while still showing a 13.2% return year to date and 53.6% over the past year. Recent coverage around the New York Times has focused on its role in the broader media sector and how investors are reassessing...